Several ribonucleases serve as cytotoxic agents in host defense and in
physiological cell death pathways. Although certain members of the pa
ncreatic ribonuclease A superfamily can be toxic when applied to the o
utside of cells, they become thousands of times more toxic when artifi
cially introduced into the cytosol, indicating that internalization is
the rate-limiting step for cytotoxicity. We have used three agents th
at disrupt the Gels apparatus by distinct mechanisms, retinoic acid, b
refeldin A, and monensin, to probe the intracellular pathways ribonucl
eases take to reach the cytosol. Retinoic acid and monensin potentiate
the cytotoxicity of bovine seminal RNase, Onconase, angiogenin, and h
uman ribonuclease A 100 times or more. Retinoic acid-mediated potentia
tion of ribonucleases is completely blocked by brefeldin A. Ribonuclea
ses appear to route more efficiently into the cytosol through the Golg
i apparatus disrupted by monensin or retinoic acid. Intracellular RNA
degradation by BS-RNase increased more than 100 times in the presence
of retinoic acid confirming that the RNase reaches the cytosol and ind
icating that degradation of RNA is the intracellular lesion causing to
xicity. As retinoic acid alone and Onconase are in clinical trials for
cancer therapy, combinations of RNases and retinoic acid in vivo may
offer new clinical utility.